BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34233454)

  • 61. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
    Thorp E; Tabas I
    J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
    Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
    J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis.
    Yamada S; Senokuchi T; Matsumura T; Morita Y; Ishii N; Fukuda K; Murakami-Nishida S; Nishida S; Kawasaki S; Motoshima H; Furukawa N; Komohara Y; Fujiwara Y; Koga T; Yamagata K; Takeya M; Araki E
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):994-1006. PubMed ID: 29496659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice.
    Pan X; Jiang XC; Hussain MM
    Circulation; 2013 Oct; 128(16):1758-69. PubMed ID: 24014832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. α4β7 Integrin (LPAM-1) is upregulated at atherosclerotic lesions and is involved in atherosclerosis progression.
    Zhi K; Li M; Zhang X; Gao Z; Bai J; Wu Y; Zhou S; Li M; Qu L
    Cell Physiol Biochem; 2014; 33(6):1876-87. PubMed ID: 24970009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.
    Li L; Najafi AH; Kitlinska JB; Neville R; Laredo J; Epstein SE; Burnett MS; Zukowska Z
    J Cardiovasc Transl Res; 2011 Jun; 4(3):351-62. PubMed ID: 21468772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Protective Functions of Liver X Receptor α in Established Vulnerable Plaques: Involvement of Regulating Endoplasmic Reticulum-Mediated Macrophage Apoptosis and Efferocytosis.
    Che X; Xiao Q; Song W; Zhang H; Sun B; Geng N; Tao Z; Shao Q; Pu J
    J Am Heart Assoc; 2021 May; 10(10):e018455. PubMed ID: 33969692
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.
    Nahon JE; Hoekstra M; van Hulst S; Manta C; Goerdt S; Geerling JJ; Géraud C; Van Eck M
    Atherosclerosis; 2019 Feb; 281():47-55. PubMed ID: 30658191
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intermedin
    Ren JL; Chen Y; Zhang LS; Zhang YR; Liu SM; Yu YR; Jia MZ; Tang CS; Qi YF; Lu WW
    Cell Death Dis; 2021 May; 12(5):436. PubMed ID: 33934111
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice.
    Du F; Yu F; Wang Y; Hui Y; Carnevale K; Fu M; Lu H; Fan D
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):759-67. PubMed ID: 24504735
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence.
    Zhu H; Wang Z; Dong Z; Wang C; Cao Q; Fan F; Zhao J; Liu X; Yuan M; Sun X; Peng X; Zou Y; Zhou J; Ge J; Zhou X; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1782-1792. PubMed ID: 30315930
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IAP survivin regulates atherosclerotic macrophage survival.
    Blanc-Brude OP; Teissier E; Castier Y; Lesèche G; Bijnens AP; Daemen M; Staels B; Mallat Z; Tedgui A
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):901-7. PubMed ID: 17255535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
    Yurdagul A
    Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.
    Kojima Y; Downing K; Kundu R; Miller C; Dewey F; Lancero H; Raaz U; Perisic L; Hedin U; Schadt E; Maegdefessel L; Quertermous T; Leeper NJ
    J Clin Invest; 2014 Mar; 124(3):1083-97. PubMed ID: 24531546
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
    Hueso M; De Ramon L; Navarro E; Ripoll E; Cruzado JM; Grinyo JM; Torras J
    Atherosclerosis; 2016 Dec; 255():80-89. PubMed ID: 27835742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.